Parkinson’s News Today: Compound similar to diabetic medications slows Parkinson’s progression in mouse study

| Posted in Brain Disease, Brain Education, Brain Research

An investigative compound similar to those used to treat diabetes was able to slow Parkinson’s progression and ease behavioral symptoms associated with the disease in mouse models. The compound, called NLY01 and developed by scientists at Johns Hopkins Medicine, works to protect against the loss of dopaminergic nerve cells — directly targeting a cause of Parkinson’s progression — and may enter clinical testing this year. (July 6, 2018)

Read the full article here